Safety study of q3w S-1 in combination with q3w trastuzumab for HER2 positive metastatic breast cancer.
Phase of Trial: Phase II
Latest Information Update: 12 May 2016
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Trastuzumab (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
- 04 Jul 2013 New trial record